Alliance’s Dolinar Headlines Boston Biosimilars Event

October 5, 2011

By Kathy Feegal Dr. Richard Dolinar, the Alliance’s chairman, was a keynote speaker at a biosimilars roundtable discussion in Boston, MA on October 5, 2011. The event was hosted by Northeastern University and was attended by numerous stakeholders from across New England, including the Massachusetts Medical Society, and patients groups such as the National Kidney […]

Read More


Biologics and Biosimilars: What Patients, Physicians and Advocates Need to Know Access, Patient Safety and Emerging Policy Issues

September 28, 2011

The Alliance for Safe Biologic Medicines joined with the Virginia Biotechnology Association at an event to expore with patients, advocates, physicians and other healthcare providers the importance of maintaining patient safety as the U.S. FDA’s top priority while it works to establish a pathway for approval for biosimilar products.

Read More


Biosimilars Policy Forum

August 17, 2011

The Alliance for Safe Biologic Medicines and Pennsylvania Bio hosted an event entitled, “Biosimilars Policy Forum: Ensuring Patient Safety” in Philadelphia, PA, on August 17, 2011 The purpose of the forum discussion was to explore with community members, including policymakers, patients, physicians, pharmacists, and hospital officials the importance of maintaining patient safety as the U.S. […]

Read More